Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | TSHR | P16473 | 4/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | PPARG | P37231 | 1/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23175186 | 0.83 | ALDH1A1 (0.48) | ALDH1A1TSHRMAPK1SMN1; SMN2TP53 | |
| SCHEMBL720089 | 0.76 | ALDH1A1 (0.53) | ALDH1A1TSHRMAPK1SMN1; SMN2TP53 | |
| SCHEMBL13979522 | 0.75 | ALDH1A1 (0.61) | ALDH1A1TSHRMAPK1SMN1; SMN2TP53 | |
| SCHEMBL28434219 | 0.74 | ALDH1A1 (0.50) | ALDH1A1TSHRMAPK1SMN1; SMN2TP53 | |
| SCHEMBL28285600 | 0.74 | ALDH1A1 (0.73) | ALDH1A1TSHRMAPK1SMN1; SMN2TP53 | |
| SCHEMBL10687266 | 0.74 | ALDH1A1 (0.50) | ALDH1A1TSHRMAPK1SMN1; SMN2TP53 | |
| SCHEMBL11352851 | 0.73 | ALDH1A1 (0.53) | ALDH1A1TSHRMAPK1SMN1; SMN2TP53 | |
| SCHEMBL28727340 | 0.72 | ALDH1A1 (0.44) | ALDH1A1TSHRMAPK1SMN1; SMN2TDP1 | |
| SCHEMBL18100542 | 0.69 | ALDH1A1 (0.73) | ALDH1A1TSHRMAPK1SMN1; SMN2TP53 | |
| SCHEMBL2734455 | 0.69 | ALDH1A1 (0.73) | ALDH1A1TSHRMAPK1SMN1; SMN2TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260085155-A1 | ORGANOPOLYSILOXANE COMPOUND AND PRODUCTION METHOD THEREOF | JNC CORPORATION (JP) | 2026-03-26 | — | — | US | disclosed |
| CN-112368641-B | Photosensitive resin composition, photosensitive sheet, cured film thereof, method for producing cured film, and electronic component | 东丽株式会社 | 2025-05-02 | — | — | CN | disclosed |
| EP-4039764-A1 | PRIMER COMPOSITION FOR GLASS ADHESIVE | KCC Corporation (KR) | 2022-08-10 | — | — | EP | disclosed |
| CN-114207520-A | Photosensitive resin composition, photosensitive sheet, cured film, method for producing cured film, interlayer insulating film, and electronic component | 东丽株式会社 | 2022-03-18 | — | — | CN | disclosed |
| WO-2021066369-A1 | PRIMER COMPOSITION FOR GLASS ADHESIVE | 주식회사 케이씨씨 | 2021-04-08 | — | — | WO | disclosed |
| CN-112368641-A | Photosensitive resin composition, photosensitive sheet, cured film of photosensitive resin composition and photosensitive sheet, method for producing cured film, and electronic component | 东丽株式会社 | 2021-02-12 | — | — | CN | disclosed |
| WO-2008124389-A1 | POLYMERIC ADHESIVE INCLUDING NANOPARTICLE FILLER | NATURALNANO, INC. (US) | 2008-10-16 | — | — | WO | disclosed |
| WO-2008124391-A1 | POLYMERIC COATINGS INCLUDING NANOPARTICLE FILLER | NATURALNANO, INC. (US) | 2008-10-16 | — | — | WO | disclosed |
| US-20080248201-A1 | POLYMERIC COATINGS INCLUDING NANOPARTICLE FILLER | NATURALNANO RESEARCH, INC. (US) | 2008-10-09 | — | — | US | disclosed |
| US-20080249221-A1 | POLYMERIC ADHESIVE INCLUDING NANOPARTICLE FILLER | NATURALNANO RESEARCH, INC. (US) | 2008-10-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260085155-A1 | ORGANOPOLYSILOXANE COMPOUND AND PRODUCTION METHOD THEREOF | FUCA1, MAN2B1, IDUA | ALDH1A1 941/4885TSHR 869/4885MAPK1 3161/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.